83
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Putting the spotlight on: CRISPR

      news
      * , 1 ,
      BioTechniques
      Future Science Ltd

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rounding up the results from our recent spotlight on CRISPR – are we still just at the beginning for our CRISPR journey?

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Guidelines for optimized gene knockout using CRISPR/Cas9

          CRISPR/Cas9 technology has evolved as the most powerful approach to generate genetic models both for fundamental and preclinical research. Despite its apparent simplicity, the outcome of a genome-editing experiment can be substantially impacted by technical parameters and biological considerations. Here, we present guidelines and tools to optimize CRISPR/Cas9 genome-targeting efficiency and specificity. The nature of the target locus, the design of the single guide RNA and the choice of the delivery method should all be carefully considered prior to a genome-editing experiment. Different methods can also be used to detect off-target cleavages and decrease the risk of unwanted mutations. Together, these optimized tools and proper controls are essential to the assessment of CRISPR/Cas9 genome-editing experiments.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Removal of extra sequences with I- Sce I in combination with CRISPR/Cas9 technique for precise gene editing in Drosophila

            The CRISPR/Cas9 system has recently emerged as a powerful tool for functional genomic studies and has been adopted for many organisms, including Drosophila . Previously, an efficient two-step strategy was developed to engineer the fly genome by combining CRISPR/Cas9 with recombinase-mediated cassette exchange (RMCE). This strategy allows the introduction of designed mutations into a gene of interest in vivo . However, the loxP or frt site remains in the edited locus. Here, we propose a modification of this approach for rapid and efficient seamless genome editing with CRISPR/Cas9 and site-specific recombinase-mediated integration (SSRMI) combined with recombination between homologous sequences induced by the rare-cutting endonuclease I- Sce I. The induced homological recombination leads to the removal of the remaining extraneous sequences from the target locus.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Combining CRISPR/Cas9-mediated knockout with genetic complementation for in-depth mechanistic studies in human ES cells

              Gene regulatory networks that control pluripotency of human embryonic stem cells (hESCs) are of considerable interest for regenerative medicine. RNAi and CRISPR/Cas9 technologies have allowed the identification of hESC regulators on a genome-wide scale. However, these technologies are ill-suited for mechanistic studies because knockdown/knockout clones of essential genes do not grow in culture. We have developed a genetic rescue strategy that combines CRISPR/Cas9-mediated knockout with TALEN-mediated integration of a doxycycline-inducible rescue transgene into a constitutive AASV1 locus. The resulting rescue clones are stable in culture, allow modulation of the rescue transgene dosage by titration of doxycycline in the media and can be combined with various molecular assays, thus providing mechanistic insights into gene function in a variety of cellular contexts.
                Bookmark

                Author and article information

                Journal
                BTN
                BioTechniques
                Future Science Ltd (London, UK )
                0736-6205
                1940-9818
                17 September 2019
                October 2019
                : 67
                : 4
                : 150-152
                Affiliations
                1Future Science Group, Unitec House, 2 Albert Place, London, N3 1QB, UK
                Author notes
                [* ]Author for correspondence: flake@ 123456biotechniques.com
                Article
                10.2144/btn-2019-0099
                c5db47f1-e9ae-4227-a91b-f554497e3b27
                © 2019 Future Science Ltd

                This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License

                History
                : 17 September 2019
                Page count
                Pages: 3
                Categories
                Tech News

                General life sciences,Cell biology,Molecular biology,Biotechnology,Genetics,Life sciences

                Comments

                Comment on this article